# Cytoprotective role of octacosanol in lipopolysaccharide-induced inflammation

**Authors:** Jingrong Tang, Zhi-Hong Yang, Wenling Li, Huaitian Liu, Diego Lucero, Denis Sviridov, Olivia White, Julia Kun, Yoh-suke Mukouyama, Alan T. Remaley

PMC · DOI: 10.3389/fimmu.2026.1770191 · Frontiers in Immunology · 2026-02-11

## TL;DR

This study shows that octacosanol, a compound in a plant-based supplement, protects blood vessel cells from inflammation caused by bacterial toxins, which may help prevent atherosclerosis.

## Contribution

The study reveals the specific molecular mechanisms by which octacosanol reduces inflammation and improves cell integrity in endothelial cells.

## Key findings

- Octacosanol reduced levels of pro-inflammatory cytokines and signaling molecules in LPS-stimulated endothelial cells.
- Octacosanol suppressed adhesion molecule expression and monocyte adhesion to endothelial cells.
- Octacosanol preserved endothelial cell junctions and reduced cell deformation and migration.

## Abstract

Inflammation and endothelial dysfunction are key steps in the pathogenesis of atherosclerosis. Octacosanol (C28H58O, OCT), a very-long-chain saturated aliphatic alcohol (VLCA) with 28 carbons, is the main component of policosanol, a nutraceutical mixture of VLCAs (C20-C34) extracted from plants. Polycosanol in animal models is known to reduce atherosclerosis, but its mechanism of action remains unclear. This study investigates the pathways by which OCT alleviates LPS-induced inflammation in primary human aortic endothelial cells (HAECs). After overnight pretreatment with purified OCT, inflammation in HAECs was induced by lipopolysaccharide (LPS) at 100 ng/ml. The effects of OCT on the levels of pro-inflammatory cytokines, and molecules involved in inflammation signaling pathway, cell adhesion, and cell integrity were examined using quantitative RT-PCR, enzyme-linked immunosorbent assay, flow cytometry, or confocal microscopy in LPS-stimulated HAECs. The group of untreated HAECs was used as a control. OCT pretreatment of HAECs significantly reduced LPS-induced inflammatory responses, decreasing levels of IL-6, IL-8, and MCP-1 mRNA and protein, as well as TLR4, MYD88, TIRAP, TRAF6, and IRAK1 mRNA (p < 0.05). In a monocyte adhesion assay, LPS exposure increased human monocytic cells (THP-1) adherence to HAECs, whereas OCT pretreatment suppressed the LPS-induced adhesion of THP-1 to HAECs in a time- and dose-dependent manner, by blocking the mRNA and protein expression of adhesion molecules (VCAM-1, ICAM-1, P- and E-SELECTIN) (p < 0.05). OCT also suppressed mRNA and protein levels of CORTACTIN, VINCULIN, and TALIN, and inhibited focal adhesion and lamellipodia formation, cell deformation, and migration in response to LPS (p < 0.05). In addition, an endothelial permeability assay revealed that OCT pretreatment also improved endothelial cell integrity after LPS stimulation by preserving both adherens junctions and tight junctions formed by VE-CADHERIN, β -CATENIN, and Zonula Occludens-1 (ZO-1) (p < 0.05). In summary, the multiple cytoprotective effects of OCT against LPS-induced inflammation in endothelial cells could contribute to the anti-atherogenic properties of policosanol.

## Linked entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615], TIRAP (TIR domain containing adaptor protein) [NCBI Gene 114609], TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189], IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654], VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412], ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], SELP (selectin P) [NCBI Gene 102247510], Sele (selectin, endothelial cell) [NCBI Gene 20339], Cortactin (cortactin) [NCBI Gene 42491], LOC110462068 (vinculin-like) [NCBI Gene 110462068], rhea (rhea) [NCBI Gene 38978], cdh5 (cadherin 5) [NCBI Gene 100488458], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441], TJP1 (tight junction protein 1) [NCBI Gene 7082]
- **Chemicals:** octacosanol (PubChem CID 68406)
- **Diseases:** atherosclerosis (MONDO:0005311)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** PLXNA2 (plexin A2) [NCBI Gene 5362] {aka OCT, PLXN2}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Traf6 (TNF receptor-associated factor 6) [NCBI Gene 22034] {aka 2310003F17Rik, C630032O20Rik}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, CTTN (cortactin) [NCBI Gene 2017] {aka EMS1}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Irak1 (interleukin-1 receptor-associated kinase 1) [NCBI Gene 16179] {aka IRAK, IRAK-1, IRAK1-S, IRAK1b, Il1rak, Plpk}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776] {aka MGF, STAT5}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Tirap (toll-interleukin 1 receptor (TIR) domain-containing adaptor protein) [NCBI Gene 117149] {aka C130027E04Rik, Mal, Tlr4ap, Wyatt}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CTNND1 (catenin delta 1) [NCBI Gene 1500] {aka BCDS2, CAS, CTNND, P120CAS, P120CTN, p120}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, TIRAP (TIR domain containing adaptor protein) [NCBI Gene 114609] {aka BACTS1, Mal, MyD88-2, wyatt}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, SELE (selectin E) [NCBI Gene 6401] {aka CD62E, ELAM, ELAM1, ESEL, LECAM2, selectin-e}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, TLN1 (talin 1) [NCBI Gene 7094] {aka ILWEQ, TLN, talin-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SELP (selectin P) [NCBI Gene 6403] {aka CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654] {aka IRAK, pelle}
- **Diseases:** HL (MESH:C538324), Inflammation (MESH:D007249), endothelial dysfunction (MESH:D014652), death (MESH:D003643), ASCVD (MESH:D050197), endothelial injury (MESH:D057772), cytotoxicity (MESH:D064420), colitis (MESH:D003092)
- **Chemicals:** CCK-8 (MESH:D012844), water (MESH:D014867), NaN3 (MESH:D019810), CMFDA (MESH:C069306), ethanol (MESH:D000431), cholesterol (MESH:D002784), FITC-Dextran (MESH:C015219), octacosanoic acid (MESH:C068792), KBr (MESH:C039004), phosphate (MESH:D010710), phalloidin (MESH:D010590), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), carbons (MESH:D002244), EDTA (MESH:D004492), LPS (MESH:D008070), 4-octyl itaconate (MESH:C000708109), lipid (MESH:D008055), To-pro-3 (MESH:C098830), CO2 (MESH:D002245), penicillin (MESH:D010406), Alexa Fluor  568-labelled LDL (-), dextran (MESH:D003911), bile acid (MESH:D001647), fatty acid (MESH:D005227), Alexa Fluor  488 (MESH:C000711379), polyester (MESH:D011091), Octacosanol (MESH:C044309), Policosanol (MESH:C080710)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HAEC — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U411), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932935/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932935/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932935/full.md

---
Source: https://tomesphere.com/paper/PMC12932935